Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DXN Holdings is a global health and wellness company that specializes in the cultivation, processing, and marketing of dietary supplements, particularly those derived from Ganoderma lucidum (Lingzhi mushroom). Founded in Malaysia, the company operates a vertically integrated business model that includes large-scale tissue culture and organic cultivation facilities. DXN is widely recognized for its multi-level marketing network, through which it distributes a diverse range of products including fortified beverages, personal care items, and health supplements. The company leverages proprietary fermentation and cold-processing technologies to maintain the bioactive integrity of its herbal ingredients. With a presence in over 180 countries, DXN continues to expand its research into the therapeutic properties of medicinal mushrooms and other natural products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DXN.